Rare CD8(+) T cells present in beta(2)microglobulin-deficient (beta(2)
m(-/-)) mice reject allogeneic tumors but not syngeneic wild-type tumo
rs, The lack of syngeneic tumor rejection in vivo is correlated with a
partial response of beta(2)m(-/-) CD8(+) cell lines to syngeneic tumo
r cells in vitro, This partial response is characterized by perforin/g
ranzyme-mediated cytolytic activity in the absence of cytokine secreti
on or proliferation, Allogeneic tumors induce cytolysis, cytokine secr
etion, and proliferation, Cytokine secretion may therefore be an impor
tant effector mechanism for tumor rejection by CD8(+) T cells, To dete
rmine the missing signaling events needed for cytokine secretion as we
ll as the events inducing the isolated cytotoxic response, we attempte
d to restore cytokine secretion of beta(2)m(-/-) CD8(+) cells to synge
neic MHC class I, Phorbol ester and syngeneic tumor cells acted synerg
istically to induce full responsiveness of beta(2)m(-/-) CD8(+) cells,
However, this synergistic induction of cytokine secretion used a diff
erent pathway than that induced by alloantigen, protein kinase C (PKC)
inhibitor prevented the syngeneic class I plus PMA-induced cytokine s
ecretion, but not allo-class I-induced cytokine secretion, In contrast
to the PKC independent alloantigen-induced cytokine secretion, cytoly
sis of both allogeneic and syngeneic targets was PKC dependent, The di
fferential dependence of effector functions on PKC activation was also
found in beta(2)m(+/+) CD8(+) T cells, Thus, two distinct signaling p
athways (PKC dependent and PKC independent) may ultimately converge to
induce cytokine secretion in CD8(+) cells, The TCR engagement-initiat
ed pathway is PKC independent, whereas the phorbol ester-activated pat
hway is PKC dependent.